molecular diagnostics

Though NGS-based methods can help circumvent the limitations of microbiology methods, several questions remain

The commutability, flexibility, and genomic complexity of cell line-derived reagents provide gold-standard controls for assay development

The pandemic has fueled new market growth and will continue to shape the future of diagnostics

Advances in nucleic acid-based detection of pathogens supports rapid sample-to-answer diagnostics for infectious disease

Automating analytical data analysis enables significant increases in sample volume

Disruptive technologies are changing the way we approach patient diagnostics and treatment

Robust IT solutions for more mainstream molecular testing

New testing platforms have the potential to transform clinical diagnostics and treatment

Why a broader range of general-purpose reagents are needed for the next pandemic

CRISPR-based diagnostics can offer quick and accurate nucleic acid testing for infectious and noninfectious diseases